Amidon GL - Search Results

1

An In Vivo Predictive Dissolution Methodology (iPD Methodology) with a BCS Class IIb Drug Can Predict the In Vivo Bioequivalence Results: Etoricoxib Products.

Gonzalez-Alvarez I, Bermejo M, Tsume Y, Ruiz-Picazo A, Gonzalez-Alvarez M, Hens B, Garcia-Arieta A, Amidon GE, Amidon GL. Gonzalez-Alvarez I, et al. Among authors: amidon gl, amidon ge. Pharmaceutics. 2021 Apr 7;13(4):507. doi: 10.3390/pharmaceutics13040507. Pharmaceutics. 2021. PMID: 33917118 Free PMC article.

2

Drug marker absorption in relation to pellet size, gastric motility and viscous meals in humans.

Rhie JK, Hayashi Y, Welage LS, Frens J, Wald RJ, Barnett JL, Amidon GE, Putcha L, Amidon GL. Rhie JK, et al. Among authors: amidon gl, amidon ge. Pharm Res. 1998 Feb;15(2):233-8. doi: 10.1023/a:1011962501270. Pharm Res. 1998. PMID: 9523309 Free article.

3

Molecular properties of WHO essential drugs and provisional biopharmaceutical classification.

Kasim NA, Whitehouse M, Ramachandran C, Bermejo M, Lennernäs H, Hussain AS, Junginger HE, Stavchansky SA, Midha KK, Shah VP, Amidon GL. Kasim NA, et al. Among authors: amidon gl. Mol Pharm. 2004 Jan 12;1(1):85-96. doi: 10.1021/mp034006h. Mol Pharm. 2004. PMID: 15832504

4

A provisional biopharmaceutical classification of the top 200 oral drug products in the United States, Great Britain, Spain, and Japan.

Takagi T, Ramachandran C, Bermejo M, Yamashita S, Yu LX, Amidon GL. Takagi T, et al. Among authors: amidon gl. Mol Pharm. 2006 Nov-Dec;3(6):631-43. doi: 10.1021/mp0600182. Mol Pharm. 2006. PMID: 17140251

5

The suitability of an in situ perfusion model for permeability determinations: utility for BCS class I biowaiver requests.

Kim JS, Mitchell S, Kijek P, Tsume Y, Hilfinger J, Amidon GL. Kim JS, et al. Among authors: amidon gl. Mol Pharm. 2006 Nov-Dec;3(6):686-94. doi: 10.1021/mp060042f. Mol Pharm. 2006. PMID: 17140256

6

Proline prodrug of melphalan, prophalan-L, demonstrates high therapeutic index in a murine melanoma model.

Mittal S, Tsume Y, Landowski CP, Lee KD, Hilfinger JM, Amidon GL. Mittal S, et al. Among authors: amidon gl. Eur J Pharm Biopharm. 2007 Nov;67(3):752-8. doi: 10.1016/j.ejpb.2007.03.024. Epub 2007 Apr 4. Eur J Pharm Biopharm. 2007. PMID: 17560100

7

Biowaiver monographs for immediate release solid oral dosage forms: aciclovir.

Arnal J, Gonzalez-Alvarez I, Bermejo M, Amidon GL, Junginger HE, Kopp S, Midha KK, Shah VP, Stavchansky S, Dressman JB, Barends DM. Arnal J, et al. Among authors: amidon gl. J Pharm Sci. 2008 Dec;97(12):5061-73. doi: 10.1002/jps.21392. J Pharm Sci. 2008. PMID: 18425814 Free article.

8

Enhanced cancer cell growth inhibition by dipeptide prodrugs of floxuridine: increased transporter affinity and metabolic stability.

Tsume Y, Hilfinger JM, Amidon GL. Tsume Y, et al. Among authors: amidon gl. Mol Pharm. 2008 Sep-Oct;5(5):717-27. doi: 10.1021/mp800008c. Epub 2008 Jul 25. Mol Pharm. 2008. PMID: 18652477 Free PMC article.

9

Enhanced absorption and growth inhibition with amino acid monoester prodrugs of floxuridine by targeting hPEPT1 transporters.

Tsume Y, Vig BS, Sun J, Landowski CP, Hilfinger JM, Ramachandran C, Amidon GL. Tsume Y, et al. Among authors: amidon gl. Molecules. 2008 Jun 28;13(7):1441-54. doi: 10.3390/molecules13071441. Molecules. 2008. PMID: 18719516 Free PMC article.

10

Toward an in vivo dissolution methodology: a comparison of phosphate and bicarbonate buffers.

Sheng JJ, McNamara DP, Amidon GL. Sheng JJ, et al. Among authors: amidon gl. Mol Pharm. 2009 Jan-Feb;6(1):29-39. doi: 10.1021/mp800148u. Mol Pharm. 2009. PMID: 19183104 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page